Recent developments in the molecular genetics of mitochondrial disorders

Area of Science:

• Genetics
• Neurology
• Mitochondrial Biology

Background:

• Mitochondrial DNA (mtDNA) mutations are increasingly identified as causes of inherited diseases.
• Established mitochondrial disorders are maternally inherited, affecting both sexes equally, with notable exceptions like Leber's hereditary optic atrophy (LHON).
• Specific mtDNA mutations are linked to distinct syndromes, including MELAS, MERRF, NARP, Leigh's syndrome, and Kearns-Sayre syndrome (KSS).

Purpose of the Study:

• To review the current understanding of mitochondrial DNA mutations associated with neurological and muscle diseases.
• To highlight specific mutations and their corresponding clinical manifestations.
• To discuss the potential role of mtDNA mutations in common neurodegenerative disorders.

Main Methods:

• Literature review of established mitochondrial disorders and their genetic basis.
• Analysis of mutation types (point mutations, deletions) and their heteroplasmic or homoplasmic states.
• Examination of the association between specific mtDNA genes (tRNA-Leu, tRNA-Lys, ATPase6) and disease phenotypes.
• Review of evidence implicating mtDNA in Parkinson's, Alzheimer's, and Huntington's diseases.

Main Results:

• Maternally inherited mtDNA mutations are linked to disorders like LHON, MELAS, MERRF, NARP, Leigh's syndrome, and KSS.
• LHON shows a higher prevalence in males, while MELAS and MERRF involve tRNA gene mutations with overlapping symptoms.
• ATPase6 gene mutations cause NARP or Leigh's syndrome, with heteroplasmy levels determining severity.
• mtDNA deletions are causative for KSS.
• Emerging evidence suggests mtDNA involvement in Parkinson's, Alzheimer's, and Huntington's diseases, though causative mutations remain unconfirmed.

Conclusions:

• Mitochondrial DNA mutations represent a significant cause of inherited neurological and muscle disorders.
• Specific mutation types and locations within mtDNA correlate with distinct clinical syndromes.
• Further research is needed to establish definitive causative mtDNA mutations in common neurodegenerative diseases like Parkinson's, Alzheimer's, and Huntington's.